Defective and Dangerous Products
DIETARY SUPPLEMENTS AND THE DIETARY SUPPLEMENT HEATH AND EDUCATION ACT (DSHEA)
Despite the fact that Americans spend billions of dollars every year on dietary supplements, these products receive very little testing before they go on the market. The Dietary Supplement Health and Education Act of 1993 (DSHEA) was passed by Congress in 1994 to amend the Federal Food, Drug, and Cosmetic Act to establish standards with [...]
CRESTOR® AND ANTI-CHOLESTEROL STATIN DRUGS
A small number of users of anti-cholesterol drugs called “statins” complain of a severe and debilitating side effect. The problems appear to be significantly more widespread in certain statin drugs that in others. Crestor® (Rosuvastatin calcium) is considered the most potent cholesterol-lowering statin drug on the market. Crestor is suspected to be the cause of [...]
CELEBREX®, BEXTRA® AND COX-2 INHIBITORS
Celebrex® (Celecoxib) is an anti-arthritis drug manufactured by Phiser. In December of 2004, FDA released the results of a post-marketing study of the drug, by advising U.S. physicians to “consider alternative therapy” to the prescription of Celebrex to patients. FDA also recommended that physicians prescribe Celebrex “only at the lowest possible dose.” The FDA stopped [...]
TIMELINE OF BREAST IMPLANT ACTIVITIES
The following is a timeline of some important dates/events in the use of breast implant appliances and related device failures. John Zodrow reminds you that this discussion is not complete but sets forth some important deadlines of which you should be aware. This discussion was compiled from publicly available information avaiable online and from legal [...]